Fungal infections in pediatric lung transplant recipients: colonization and invasive disease
- PMID: 19782585
- PMCID: PMC2782648
- DOI: 10.1016/j.healun.2009.06.006
Fungal infections in pediatric lung transplant recipients: colonization and invasive disease
Abstract
Background: The purpose of this study was to evaluate the epidemiology and investigate the impact of colonization and pulmonary fungal infections (PFIs).
Methods: In this investigation we performed a retrospective analysis of 55 pediatric lung transplant recipients from 2002 to 2007 at a single institution. Associations between risk factors and time to post-transplant colonization, PFI, and other outcomes were assessed using Cox proportional hazard models.
Results: Although 29 patients had positive pre-transplant colonization, 33 (60%) were colonized post-transplant and 20% (11 subjects) developed proven or probable PFI. In a multivariate model, post-transplant fungal colonization was associated with older age (hazard ratio [HR] 2.9, 95% confidence interval [CI] 1.1 to 7.6), cytomegalovirus (CMV) prophylaxis (HR 5.6, 95% CI 1.3 to 24.6) and respiratory viral infection prior to fungal colonization (HR 2.9, 95% CI 1.0 to 8.3).
Conclusion: Neither fungal colonization nor PFI was associated with the development of chronic allograft rejection or death.
Figures
Similar articles
-
Risk and outcomes of pulmonary fungal infection after pediatric lung transplantation.Clin Transplant. 2017 Nov;31(11):10.1111/ctr.13100. doi: 10.1111/ctr.13100. Epub 2017 Sep 18. Clin Transplant. 2017. PMID: 28871606 Free PMC article.
-
Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation.J Heart Lung Transplant. 2008 Jun;27(6):655-61. doi: 10.1016/j.healun.2008.03.010. Epub 2008 Apr 24. J Heart Lung Transplant. 2008. PMID: 18503966 Free PMC article.
-
Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.J Heart Lung Transplant. 2009 Oct;28(10):1050-6. doi: 10.1016/j.healun.2009.04.032. J Heart Lung Transplant. 2009. PMID: 19782286 Free PMC article.
-
Fungal Infections After Lung Transplantation.Clin Chest Med. 2017 Sep;38(3):511-520. doi: 10.1016/j.ccm.2017.04.011. Epub 2017 May 20. Clin Chest Med. 2017. PMID: 28797492 Free PMC article. Review.
-
Risk factors of invasive fungal infections in lung transplant recipients: A systematic review and meta-analysis.J Heart Lung Transplant. 2022 Feb;41(2):255-262. doi: 10.1016/j.healun.2021.09.014. Epub 2021 Oct 3. J Heart Lung Transplant. 2022. PMID: 34872817
Cited by
-
Epidemiology of Invasive Fungal Disease in Children.J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S3-S11. doi: 10.1093/jpids/pix046. J Pediatric Infect Dis Soc. 2017. PMID: 28927200 Free PMC article. Review.
-
Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation.J Fungi (Basel). 2020 Dec 21;6(4):381. doi: 10.3390/jof6040381. J Fungi (Basel). 2020. PMID: 33371198 Free PMC article. Review.
-
Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S12-S21. doi: 10.1093/jpids/pix053. J Pediatric Infect Dis Soc. 2017. PMID: 28927201 Free PMC article. Review.
-
Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Semin Respir Crit Care Med. 2015 Apr;36(2):299-320. doi: 10.1055/s-0035-1547347. Epub 2015 Mar 31. Semin Respir Crit Care Med. 2015. PMID: 25826595 Free PMC article. Review.
-
Macrophage Lysosomal Alkalinization Drives Invasive Aspergillosis in a Mouse Cystic Fibrosis Model of Airway Transplantation.J Fungi (Basel). 2022 Jul 20;8(7):751. doi: 10.3390/jof8070751. J Fungi (Basel). 2022. PMID: 35887506 Free PMC article.
References
-
- Cahill BC, Hibbs JR, Savik K, Juni BA, Dosland BM, Edin-Stibbe C, et al. Aspergillus airway colonization and invasive disease in lung transplant. Chest. 1997;112:1160–1164. - PubMed
-
- Husni RN, Gordon SM, Longworth DL, Arroliga A, Stillwell PC, Avery RK, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis. 1998;26(3):753–755. - PubMed
-
- Mehrad B, Paciocco G, Martinez FJ, Ojo TC, Iannettoni MD, Lynch JP., 3rd Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest. 2001;119(1):169–175. - PubMed
-
- Minari A, Husni R, Avery RK, Longworth DL, DeCamp M, Bertin M, et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis. 2002;4(4):195–200. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical